Drug Shortage Report for TEVA-NYSTATIN

Last updated on 2024-02-22 History
Report ID 218952
Drug Identification Number 02194201
Brand name TEVA-NYSTATIN
Common or Proper name NYSTATIN 100MU/ML DROPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) NYSTATIN
Strength(s) 100000UNIT
Dosage form(s) SUSPENSION
Route of administration ORAL ORAL
Packaging size 100ml
ATC code A07AA
ATC description INTESTINALANTIINFECTIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-02-07
Estimated end date 2024-04-10
Actual end date
Shortage status Actual shortage
Updated date 2024-02-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2024-02-22 French Compare
v5 2024-02-22 English Compare
v4 2024-02-08 French Compare
v3 2024-02-08 English Compare
v2 2024-02-08 French Compare
v1 2024-02-08 English Compare

Showing 1 to 6 of 6